Link to this page

Your search term(s) "hypoglycemia" returned 234 results.

Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24    Display All

Reactive and Fasting Hypoglycemia. 3rd ed. Minneapolis, MN: International Diabetes Center. 2004. [8 p.].

Fasting hypoglycemia (low blood glucose in people who have not eaten for at least eight hours) can be caused by certain conditions that upset the body's ability to balance blood glucose. These conditions include eating disorders, as well as conditions involving the pancreas, pituitary, or adrenal glands, liver, or kidneys. Reactive hypoglycemia occurs after eating meals or snacks that contain mainly carbohydrate foods. Normally, the body would immediately release enough insulin to balance the carbohydrate. With reactive hypoglycemia, insulin is released later and exceeds the amount needed to cover the carbohydrate. This brochure introduces fasting and reactive hypoglycemia and helps readers with diabetes learn how to recognize and avoid these complications. Topics include the causes of hypoglycemia, symptoms, carbohydrate counting, the treatment of hypoglycemia, and practical suggestions for preventing hypoglycemia. Food charts, listing carbohydrate values of common foods, are provided. 1 table.

Full Record   Printer Friendly Version

Reduced Severe Hypoglycemia with Insulin Glargine in Intensively Treated Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 6(5): 589-595. October 2004.

The goal of new therapies introduced for type 1 diabetes should be to decrease hypoglycemic episodes while improving glycemic control. This article reports on a study in which a database was used to computer match the baseline A1C (glycosylated hemoglobin, a measure of blood glucose over time) values in 196 subjects with type 1 diabetes receiving multiple daily injections (MDI) consisting of four or more injections per day. There were 98 patients transferred from NPH to insulin glargine, and 98 patients who remained on NPH throughout the study. The gender distribution and mean age (32 years), duration of diabetes (16 years), and duration of treatment (13 months) were not significantly different between the groups. The majority of patients were well controlled (more 50 percent in both groups had an A1c less than 7 percent). The mean A1C values were not significantly different in the groups at baseline or at follow-up. Severe hypoglycemic episodes per patient per year were significantly lower in the glargine group compared with the NPH group (0.5 vs. 1.2 respectively). The mean end-of-study total and long-acting doses were significantly reduced from baseline in the group that switched to glargine, but not in the group that remained on NPH, with no change in the short-acting dose in either group. The weight gain was significantly higher in the NPH group at the end of the study with no significant change in the glargine group. The authors conclude that transfer to glargine treatment from NPH in MDI regimens significantly reduces severe hypoglycemic episodes despite a decline in long-acting basal insulin without significant weight gain. 2 figures. 1 table. 21 references.

Full Record   Printer Friendly Version

Taking Charge of Diabetes: A Diary.

This booklet helps people newly diagnosed with diabetes to record and understand their food intake. Understanding food intake and blood glucose levels is the first step to controlling diabetes. The booklet begins with a discussion of some basics of diabetes management, including the importance of frequent blood glucose testing, high blood glucose (hyperglycemia) levels and their symptoms, how to know when symptoms consist an emergency that needs treatment, low blood glucose (hypoglycemia) symptoms and emergency care, the importance of exercise, stress reduction, the different types of meal planning (exchange lists, carbohydrate counting) that may be utilized, food labels, weight loss, and complications and how to prevent them. Most of the brochure consists of a blank food diary that covers three meals plus snacks every day for 11 weeks. Simple exchange lists are provided. The back cover of the brochure provides space for a dietitian or other health care provider to note the recommended personal meal plan. Throughout the brochure facts and practical tips are noted. The brochure is illustrated with cartoon line drawings.

Full Record   Printer Friendly Version

Type 2 Diabetes BASICS Curriculum Guide. 2nd ed. Minneapolis, MN: International Diabetes Center. 2004. 146 p.

This book is an education program for people with type 2 diabetes who are not treated with insulin. The book is designed to be used as part of a program which is usually taught by certified diabetes educators (CDEs). The book is divided into four sections to coincide with the four sessions of the program. The first section introduces the disease and what causes it, how diabetes is treated, the goals of treatment, blood glucose testing, carbohydrate foods, counting carbohydrates, the role of physical activity, and self-care. The second section covers SMBG (self monitoring of blood glucose), hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose) and how to treat them, the impact of stress and illness on blood glucose, additional carbohydrate counting strategies, following a food plan even at restaurants or while traveling, the impact of alcohol, and how to feel more confident about dealing with diabetes. The third section focuses on the glycosylated hemoglobin (HbA1c) test and why blood glucose levels may be out of target, how diabetes and treatment change over time, the patient health care team, complications and how they can be prevented, the role of dietary fats and how to reduce them, and self care. The final section emphasizes the importance of problem solving skills and strategies for creating life balance, including in the areas of food and nutrition, psychological aspects, and health weight loss. The book is filled with illustrations and charts to help make the information more accessible. Appendices and a glossary of terms complete the volume.

Full Record   Printer Friendly Version

Absence of Adverse Effects of Severe Hypoglycemia on Cognitive Function in School-Aged Children With Diabetes Over 18 Months. Diabetes Care. 26(4): 1100-1105. April 2003.

Some children with type 1 diabetes may be at risk of cognitive impairments, but mechanisms of this effect have not been confirmed. This article reports on a study undertaken to determine whether severe hypoglycemia (SH) in children with type 1 diabetes is associated with cognitive decline over 18 months. A sample of 142 children (age 6 to 15 years) with type 1 diabetes enrolled in a trial of intensive therapy (IT) or usual care (UC) were tested with a cognitive assessment tool at baseline and at 9 and 18 months. HbA1c (glycosylated hemoglobin, a measure of blood glucose levels over time) was tested quarterly. Over 18 months, 58 of 142 patients (41 percent) experienced 111 SH episodes. Neither occurrence nor frequency of SH was associated with decline in full-scale intelligence quotient (IQ), standard scores for planning, attention, simultaneous processing, or successive processing, or scaled scores on any of eight subtests. The same findings emerged when only patients who had experienced hypoglycemic seizures or coma were included in the SH group for analyses. HbA1c during the trial was not associated with cognitive changes. SH did not induce adverse changes in the measures of cognitive function in this study. 1 figure. 3 tables. 27 references.

Full Record   Printer Friendly Version

Acarbose. In: Patel, A. Diabetes in Focus. 2nd ed. Lewisville, TX: Pharmaceutical Press. 2003. p. 119-122.

Diabetes mellitus is a common chronic disorder and represents a serious health care challenge. The prevalence of diabetes is increasing worldwide and considerable progress has been made in the understanding of diabetes management. This chapter on drug therapy with acarbose is from a textbook that details the practical pharmaceutical care that pharmacists can provide for people with diabetes. In this chapter, the author reviews the use of acarbose in combination with other antidiabetes drugs for reducing post-prandial hyperglycemia (high blood glucose levels occurring after a meal). Topics include mechanism of action, pharmacokinetics, contraindications, dosage, adverse effects (notably hypoglycemia), drug interactions, and preparations. 1 figure. 5 references.

Full Record   Printer Friendly Version

B-cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial. Diabetes Care. 26(3): 832-836. March 2003.

In patients with type 1 diabetes, measurement of connecting peptide (C-peptide), co-secreted with insulin from the islets of Langerhans, permits estimation of remaining beta cell secretion of insulin. This article reports on a retrospective analysis undertaken to distinguish the incremental benefits of residual beta cell activity in type 1 diabetes. In the study, stimulated (90 minutes following ingestion of a mixed meal) C-peptide levels were related to measures of diabetic retinopathy (eye disease) and nephropathy (kidney disease) and to incidents of severe hypoglycemia (low blood glucose levels). Results showed that uniformly in the intensive group and partially in the conventional treatment group, any C-peptide secretion, but especially at higher and sustained levels of stimulated C-peptide, was associated with reduced incidences of both retinopathy and nephropathy. Also, continuing C-peptide (insulin) secretion is important in avoiding hypoglycemia (the major complication of intensive diabetes therapy). 1 figure. 4 tables. 22 references.

Full Record   Printer Friendly Version

Core Curriculum for Diabetes Education. 5th ed.: (Volume 2) Diabetes Management Therapies. Chicago, IL: American Association of Diabetes Educators (AADE). 2003. 341 p.

This guidebook is the second in a series of four handbooks in the CORE Curriculum, a project originally planned to help educators prepare for the Certified Diabetes Educators (CDE) exam. However, the use and scope of the CORE Curriculum has expanded; it is both a key reference for the Advanced Diabetes Management credential exam and an authoritative source of information for diabetes education, training, and management. This first volume covers diabetes management therapies. Topics include medical nutrition therapy for diabetes; physical activity and exercise; pharmacologic (drug) therapies for glucose management; pharmacologic therapies for hypertension (high blood pressure) and dyslipidemia (altered levels of blood fats, including cholesterol); monitoring; pattern management of blood glucose; insulin pump therapy and carbohydrate counting for pump therapy, including the use of insulin-to-carbohydrate ratios; hypoglycemia (low blood glucose levels); and coping with illness and surgery. Each chapter includes an introduction, a list of learning objectives, key definitions (glossary), key educational considerations, self review questions, references, and a post-test (including an answer key). The handbook concludes with a subject index.

Full Record   Printer Friendly Version

Diabetes and Driving Mishaps: Frequency and Correlations from a Multinational Survey. Diabetes Care. 26(8): 2329-2334. August 2003.

The intensive treatment of diabetes to achieve strict glycemic control is a common clinical goal, but it is associated with an increased incidence of hypoglycemia. Becoming hypoglycemic while driving is a hazardous condition and may lead to a greater incidence of driving mishaps. This article reports on a study that investigated whether diabetes is associated with increased risk of driving mishaps and the correlates of such a relationship. During routine visits to diabetes specialty clinics in seven United States and European cities, consecutive adults with type 1 diabetes, type 2 diabetes, and nondiabetic spouse control subjects (n = 341, 332, and 363, respectively) completed an anonymous questionnaire concerning diabetes and driving. Results showed that drivers with type 1 diabetes reported significantly more crashes, moving violations, episodes of hypoglycemic stupor, required assistance, and mild hypoglycemia while driving as compared with drivers with type 2 diabetes or spouse control subjects. Drivers with type 2 diabetes had driving mishap rates similar to nondiabetic spouses, and the use of insulin or oral agents for treatment had no effect on the occurrence of driving mishaps. Crashes among type 1 diabetes drivers were associated with more frequent episodes of hypoglycemic stupor while driving, less frequent blood glucose monitoring before driving, and the use of insulin injection therapy as compared with pump therapy. One-half of the drivers with type 1 diabetes and three-quarters of the drivers with type 2 diabetes had never discussed hypoglycemia and driving with their physicians. 2 tables. 21 references.

Full Record   Printer Friendly Version

Diabetes in Infants and Toddlers. Alexandria, VA: American Diabetes Association. 2003. 5 p.

This document is a type of fact sheet that is available online, called PODs (print-on-demand). The fact sheets accompany the Wizdom patient education book series from the American Diabetes Association (ADA); the series is designed for children and adolescents and their families. This fact sheet discusses diabetes in infants and toddlers. Topics include coping with a diagnosis in a very young child, the importance of getting support, emotional considerations, monitoring blood glucose levels, managing a baby's diabetes, working with the patient care team, insulin management, symptoms of hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose) in babies, and using non-food items for rewards. The fact sheet concludes with suggestions for additional information (web sites and other publications). The fact sheets are also available in print format from the ADA (800-342-2383).

Full Record   Printer Friendly Version

Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24    Display All

Start a new search.